Newsroom

Sorted by: Latest

-

Faraday Future Announces the Launch of the Early Reservation Portal for Faraday X (FX) Official FX Super One B2C Pre-order Portal for Individual Users Building Upon the Success of the B2B Outreach

LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a California-based global shared intelligent electric mobility ecosystem company, today announced the launch of early reservation portal for Faraday X (FX) official FX Super One B2C reservation for all individual users. Starting tomorrow, users who complete pre-registration and place a deposit will receive a unique FF ID and a confirmed queue number for earlier delive...
-

Newegg Launches 11th Annual FantasTech Sale with Thousands of Tech Deals in the US and Canada

DIAMOND BAR, Calif.--(BUSINESS WIRE)--Newegg Commerce, Inc. (NASDAQ: NEGG) (the “Company”), a leading global tech e-retailer, today launched its 11th annual FantasTech Sale, one of the company’s biggest sales events of the year. Running from July 7 through July 13, the event features thousands of PC and tech deals across Newegg.com and Newegg.ca, spanning more than 50 product categories and offering deep discounts on everything from gaming laptops and desktop PCs to components, peripherals, and...
-

Linqto, Inc. Issues the Following Statement in Response to Deceptive Statements from Matt Rosendin of CapSign Concerning Linqto’s Ripple Holdings

SAN JOSE, Calif.--(BUSINESS WIRE)--Linqto, Inc. (“Linqto” or the “Company”) today issued the following statement in response to a deceptive post on X by Matt Rosendin, Founder and CEO of CapSign, concerning holdings of Ripple shares by Linqto Liquidshares, LLC (“Liquidshares”). A thread posted on X by Mr. Rosendin falsely indicated that a private equity fund being established by CapSign holds the 4.7 million of Ripple shares held by Liquidshares. “Contrary to published reports on X, Linqto conf...
-

Nihon Global Growth Partners Comments on Results of Toyo Suisan’s 2025 Annual General Meeting

NEW YORK & TOKYO--(BUSINESS WIRE)--Nihon Global Growth Partners (“NHGGP”), a long-term shareholder of Toyo Suisan Kaisha Ltd. (2875.T) (“Toyo Suisan” or the “Company”), today issued the following statement regarding the results of the Company’s 77th Annual General Meeting of Shareholders held on June 26, 2025: “NHGGP is grateful for fellow shareholders’ continuing support for meaningful change at Toyo Suisan. At the 2025 AGM, NHGGP’s board nominees – Mr. Kotaro Okamura and Mr. Masami Kashiwakur...
-

CorFlow Therapeutics、新しい心臓発作ケア技術を検証するMOCA-II IDEピボタル試験のFDA承認を発表

スイス、バール--(BUSINESS WIRE)--(ビジネスワイヤ) -- 微小血管疾患を標的とした心臓疾患ケア領域のパイオニア企業であるCorFlow Therapeutics AG (CorFlow)は、同社の技術の治験医療機器に対する適用免除(IDE)を米国食品医薬品局(FDA)が承認したと発表しました。これにより、米国の病院でピボタル試験(医薬品の有効性・安全性を証明するための極めて重要な臨床試験)が開始できるようになります。CorFlowは今後、これらの治験実施施設がCorFlowシステムを受け取り、研修を受け、心臓発作の治療中の患者の登録を開始できるよう準備を進めていきます。 IDEピボタル試験であるMOCA-IIは、プライマリー経皮的冠動脈インターベンション(PCI)手技中の微小血管閉塞(MVO)の有無の判定において、独自のCorFlow CoFlシステムの診断精度を前向きに検証することを目的としています。主要評価項目では、CoFIによる診断的読解を、心臓MRIスキャンにより診断の参照基準と比較しました。この試験は、米国と欧州の一流研究機関でST上昇型心筋梗塞(STE...
-

Nakiki SE planea realineación estratégica para alcanzar una estrategia de tesoro “exclusiva” en Bitcoin

FRANKFURT AM MAIN, Alemania--(BUSINESS WIRE)--Nakiki SE (ISIN: DE000WNDL300) está planificando una realineación estratégica con el objetivo de convertirse en la primera empresa que cotiza sus valores en el mercado alemán con una estrategia de tesoro exclusiva en Bitcoin. Por estrategia de tesoro en Bitcoin, se hace referencia a cuando una empresa enfoca sus inversiones en el Bitcoin. Hoy se definieron los pasos a seguir para desarrollar una cartera en Bitcoin, tras conversaciones con posibles i...
-

Swisslog Healthcare Welcomes New Global Head of People & Organization

BROOMFIELD, Colo.--(BUSINESS WIRE)--Swisslog Healthcare, a leading supplier in transport and pharmacy automation solutions, appoints Sarah Stary as the new Global Head of People & Organization. Stary brings over 18 years of global experience in human resources strategy, organizational development, and culture transformation to the role. In her new role, Stary will develop and execute people-centric strategies that support business growth, enhance organizational effectiveness, and drive a cu...
-

OPEX® Corporation to Showcase Advanced Warehouse Automation Solutions at CeMAT AUSTRALIA

MOORESTOWN, N.J.--(BUSINESS WIRE)--OPEX® Corporation, a global leader in Next Generation Automation providing innovative solutions for warehouse, document and mail automation, will showcase its advanced warehouse automation technology at CeMAT AUSTRALIA, July 22 through 24, 2025, at The Dome, Sydney Olympic Park. CeMAT is the world’s leading trade show for intralogistics, materials handling and supply chain management, drawing attendees from across Australia, China, Italy, Turkey and Singapore....
-

Lubrizol的Apinovex™聚合物荣获2025年世界制药原料中国展药用辅料奖

克利夫兰--(BUSINESS WIRE)--(美国商业资讯)-- Lubrizol的Apinovex™聚合物在6月24日至26日于上海举办的世界制药原料中国展(CPhI China)上荣获药用辅料奖类别的表彰奖。CPhI通过多渠道活动和各地区数字平台为全球制药供应链提供支持,行业专业人士可在此就原料药(API)、合同开发与生产组织(CDMO)、辅料等进行交流、学习与合作。 Apinovex聚合物的获奖使其与Lubrizol另一款新型辅料Apsisolex™聚合物并肩而立,后者已斩获多项大奖,包括2023年CPhI全球创新奖,以及2023年度Medicine Maker创新奖最高奖。这些奖项彰显了Lubrizol将下一代辅料技术推向市场的承诺,该技术可提高原料药的溶解度和生物利用度,从而优化药物递送效果。 Lubrizol新型聚合物全球商务经理Matt Finkelhor表示:“我们的新型注射用辅料Apsisolex™聚合物此前已获得多项创新大奖,此次再获CPhI的认可,我们深感振奋。这些奖项证实,Lubrizol的创新正在改变药物递送解决方案——通过提高生物利用度,助力将更多改变生命...
-

NASDAQ: SRPT: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Class Action Lawsuit Against Sarepta Therapeutics, Inc.

RADNOR, Pa.--(BUSINESS WIRE)--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Sarepta Therapeutics, Inc. (“Sarepta”) (NASDAQ: SRPT) on behalf of those who purchased or otherwise acquired Sarepta securities between June 22, 2023, and June 24, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is August 25, 2025. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered Sarep...